Kinarus Therapeutics Holding AG
SIX:CURN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kinarus Therapeutics Holding AG
SIX:CURN
|
CH |
|
PYC Therapeutics Ltd
ASX:PYC
|
AU |
|
N
|
Nuance Communications Inc
F:SC2
|
US |
|
A
|
Automatic Data Processing Inc
SWB:ADP
|
US |
Shareholder Yield
Current shareholder yield for 
CURN is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CURN Price
Kinarus Therapeutics Holding AG
| Average Annual Return | 110.83% |
| Standard Deviation of Annual Returns | 332.39% |
| Max Drawdown | -100% |
| Market Capitalization | 19.5B CHF |
| Shares Outstanding | 5 150 000 |
| Percentage of Shares Shorted |
N/A
|
CURN Return Decomposition
Main factors of price return
Stock Splits
CURN's latest stock split occurred on Apr 26, 2024
The company executed a 1-for-4480 stock split, meaning that for every 4480 shares held, investors received 1 new share.
Before the split, CURN traded at 16.128 per share. Afterward, the share price was about 15.
The adjusted shares began trading on Apr 26, 2024. This was the only stock split in CURN's history.
